Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukaemia: A randomised, heparin-controlled pilot study
- 1 April 1994
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 74 (1) , 65-75
- https://doi.org/10.1016/0049-3848(94)90036-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Multiple thrombosis in acute promyelocytic leukaemia after tretinoinThe Lancet, 1993
- ACUTE PROMYELOCYTIC LEUKAEMIABritish Journal of Haematology, 1992
- Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosisBritish Journal of Surgery, 1992
- Dermatan sulphate in haemodialysisThe Lancet, 1992
- Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in RabbitsaAnnals of the New York Academy of Sciences, 1989
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Acute promyelocytic leukemiaAmerican Journal of Hematology, 1979
- The Procoagulant Factor of Leukaemic Promyelocytes: Demonstration of Immunologic Cross Reactivity with Human Brain Tissue FactorBritish Journal of Haematology, 1975
- Relationship between Blast-Cell Morphology and Occurrence of a Syndrome of Disseminated Intravascular CoagulationBritish Journal of Haematology, 1973
- Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic LeukaemiaBritish Journal of Haematology, 1973